Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate UpdateGlobeNewsWire • 11/09/22
Biotech Stock Catalyst Pharmaceuticals Offers Buy Point Ahead Of EarningsInvestors Business Daily • 11/03/22
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022GlobeNewsWire • 10/25/22
Is Catalyst Pharmaceuticals (CPRX) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 10/03/22
Catalyst Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric PatientsGlobeNewsWire • 09/29/22
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This YearInvestors Business Daily • 09/19/22
Looking for a Growth Stock? 3 Reasons Why Catalyst (CPRX) is a Solid ChoiceZacks Investment Research • 09/15/22
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarinInvestors Business Daily • 09/15/22
Is Catalyst Pharmaceuticals (CPRX) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 09/15/22
Catalyst Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/09/22